|
212Pb-DOTAM Clinical Trials
1 actively recruiting trial across 1 location
No change since September 2026
Also known as: RO7205834-010
Chicago, Illinois1 trial
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
The University of Chicago Medical Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.